Overview

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Status:
Terminated

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this new research study is to gain additional information about how safe and effective R935788 is over a longer period of time.

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca